aspirin has been researched along with thalidomide in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (25.00) | 18.7374 |
1990's | 2 (3.13) | 18.2507 |
2000's | 21 (32.81) | 29.6817 |
2010's | 23 (35.94) | 24.3611 |
2020's | 2 (3.13) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barbieri, KP; Capote, TSO; Carlos, IZ; Chegaev, K; Chelucci, RC; Chung, MC; Coelho, F; Costa, FF; Dos Santos, JL; Fernandes, GFDS; Fruttero, R; Guglielmo, S; Kumkhaek, C; Lanaro, C; Lopes Pires, ME; Marcondes, S; Melo, TRF; Rodgers, GP | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Shepard, TH | 1 |
Sheskin, J | 1 |
Yaffe, SJ | 1 |
Pfaltzgraff, RE | 1 |
Gavan, JA; Wilson, JG | 1 |
Palmer, AK | 2 |
Wilson, JG | 1 |
Tanimura, T | 1 |
Bechelli, LM; De las Aguas, JT; Iyer, CG; Languillon, J; Martinez Dominguez, V; Ramanujam, K; Sundaresan, T; Tarabini-Castellani, G; Uemura, K | 1 |
McColl, JD | 2 |
Globus, M; McColl, JD; Robinson, S | 2 |
Arlen, RR; Wells, PG | 1 |
Ray, WA | 1 |
Bruera, E; Peuckmann, V; Strumpf, M; Zenz, M | 1 |
BROWN, RA; WEST, GB | 1 |
Brown, K; Chanan-Khan, A; Hahn, T; McCarthy, PL; Paplham, P; Roy, H; Scarpace, SL; van Besien, K | 1 |
Owen, OG | 1 |
Andresen, S; Baz, R; Faiman, B; Hussein, MA; Jawde, RA; Karam, MA; Kottke-Marchant, K; Li, L; McGowan, B; Srkalovic, G; Yiannaki, E; Zeldis, J | 1 |
Rajkumar, SV | 1 |
Barlogie, B; Crowley, J; Durie, BG; Hussein, MA; McCoy, J; Zonder, JA | 1 |
Boccadoro, M; Palumbo, A; Rodeghiero, F; Rus, C; Zeldis, JB | 1 |
Hirsh, J | 1 |
Dunkley, S; Gaudry, L | 1 |
Hashimoto, Y; Hirano, T; Ito, Y; Mori, A; Uchino, M; Yonemura, K | 1 |
Lockwood, DN; Walker, SL; Waters, MF | 1 |
Christos, P; Coleman, M; De Sancho, M; Furst, J; Jalbrzikowski, J; Jayabalan, D; Leonard, J; Mark, T; Martínez-Baños, D; Mazumdar, M; Niesvizky, R; Pearse, R; Pekle, K; Zafar, F | 1 |
Anderson, KC; Attal, M; Barlogie, B; Belch, A; Bladé, J; Boccadoro, M; Bringhen, S; Cavo, M; Dimopoulos, MA; Durie, BG; Harousseau, J; Hussein, MA; Joshua, D; Knop, S; Kyle, R; Lonial, S; Ludwig, H; Morgan, GJ; Niesvizky, R; Orlowski, RZ; Palumbo, A; Rajkumar, SV; Richardson, PG; San Miguel, J; Sezer, O; Shimizu, K; Sonneveld, P; Vesole, D; von Lilienfeld-Toal, M; Waage, A; Weber, D; Westin, J; Zangari, M; Zonder, JA | 1 |
Paydas, S | 1 |
Martínez-Baños, DM; Niesvizky, R | 1 |
Dahdaleh, FS; Musallam, KM; Shamseddine, AI; Taher, AT | 1 |
Lacut, K; Mottier, D; Pottier, P | 1 |
Lockwood, DN; Ramirez, J; Richardus, JH; van Brakel, WH; Van Veen, NH | 2 |
Beghin, D; Claude, N; Delongeas, JL; Farinotti, R; Forestier, F; Gil, S | 1 |
Sirven, JI | 1 |
Gajra, A; Singh, A | 1 |
Baldini, L; Benevolo, G; Boccadoro, M; Bringhen, S; Callea, V; Caravita, T; Carella, AM; Cavo, M; Cellini, C; Crippa, C; Elice, F; Evangelista, A; Galli, M; Gentilini, F; Magarotto, V; Marasca, R; Montefusco, V; Morabito, F; Nozzoli, C; Offidani, M; Palumbo, A; Patriarca, F; Pescosta, N; Polloni, C; Pulini, S; Ria, R; Romano, A; Rossi, D; Tacchetti, P; Tosi, P; Zamagni, E; Zambello, R | 1 |
Brioli, A; Cavo, M; Pantani, L; Tacchetti, P; Zamagni, E; Zannetti, B | 1 |
Gonçalves, LL; Lee, CJ; Wells, PG | 1 |
Beggiato, E; Boccadoro, M; Bringhen, S; Cafro, AM; Carella, AM; Catalano, L; Cavalli, M; Cavallo, F; Cavo, M; Corradini, P; Crippa, C; Di Raimondo, F; Di Toritto, TC; Evangelista, A; Falanga, A; Larocca, A; Nagler, A; Palumbo, A; Patriarca, F; Peccatori, J; Petrucci, MT; Pezzatti, S; Siniscalchi, A; Stanevsky, A; Yehuda, DB | 1 |
Kristinsson, SY; Landgren, O | 1 |
Alexander, M; Kirsa, S; Mellor, JD | 1 |
Jian, X; Liu, H; Zhang, W; Zhang, Z; Zhou, Q | 1 |
Alexander, M; Kirsa, S; Lingaratnam, S; Mellor, JD; Teoh, KC | 1 |
Hattori, K; Ichikawa, A; Igarashi, A; Kato, A; Koshino, M; Nagata, K; Takano, H | 1 |
Bagratuni, T; Dimopoulos, MA; Eleutherakis-Papaiakovou, E; Gavriatopoulou, M; Kanelias, N; Kastritis, E; Kostouros, E; Politou, M; Roussou, M; Terpos, E | 1 |
Miyamoto, T; Yoshimoto, G | 1 |
Patnaik, MM; Tefferi, A | 1 |
Bartlett, NL; Blum, KA; Cheson, BD; Czuczman, M; Giguere, JK; Johnson, J; Jung, SH; Leonard, JP; Pitcher, BN | 1 |
Bhattarai, D; Choi, Y; Hyeon Han, S; Jang, Y; Lee, K; Singh, S | 1 |
Al-Ani, F; Bermejo, JM; Louzada, M; Mateos, MV | 1 |
Leebeek, FW | 1 |
Chalayer, E; Chapelle, C; Elalamy, I; Laporte, S; Leleu, X; Tardy, B | 1 |
Cantero-Fortiz, Y; Cruz-Mora, A; García-Navarrete, YI; León-Peña, A; Murrieta-Álvarez, I; Olivares-Gazca, JC; Olivares-Gazca, M; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Steensma, DP | 1 |
19 review(s) available for aspirin and thalidomide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Present status of drugs as teratogens in man.
Topics: Abnormalities, Drug-Induced; Alkylating Agents; Anti-Bacterial Agents; Anticonvulsants; Antiemetics; Antitubercular Agents; Appetite Depressants; Aspirin; Cortisone; Drug-Related Side Effects and Adverse Reactions; Embryonic and Fetal Development; Female; Fetal Diseases; Folic Acid Antagonists; Humans; Hypoglycemic Agents; Imipramine; Lysergic Acid Diethylamide; Meclizine; Pregnancy; Steroids; Sulfonamides; Thalidomide; Tranquilizing Agents | 1973 |
Clinical studies of drug effects in humans.
Topics: Aspirin; Case-Control Studies; Cohort Studies; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Epidemiologic Factors; Humans; Randomized Controlled Trials as Topic; Thalidomide | 1996 |
[Novel potential uses of thalidomide in the management of pain? A review of the literature].
Topics: Analgesics; Aspirin; Caffeine; Drug Therapy, Combination; Humans; Pain; Phenacetin; Thalidomide | 2003 |
Risk of thrombosis with lenalidomide and its prevention with aspirin.
Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Humans; Lenalidomide; Multiple Myeloma; Thalidomide; Venous Thrombosis | 2007 |
[Brief report: stroke in multiple myeloma patient treated with thalidomide].
Topics: Aged; Anticoagulants; Aspirin; Embolism, Paradoxical; Foramen Ovale, Patent; Humans; Male; Multiple Myeloma; Neuroprotective Agents; Risk; Stockings, Compression; Stroke; Thalidomide; Venous Thrombosis; Warfarin | 2007 |
The role of thalidomide in the management of erythema nodosum leprosum.
Topics: Aspirin; Controlled Clinical Trials as Topic; Decision Trees; Erythema Nodosum; Humans; Leprostatic Agents; Pentoxifylline; Thalidomide | 2007 |
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
Topics: Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Premedication; Risk Assessment; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin | 2008 |
Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
Topics: Arsenic Trioxide; Arsenicals; Aspirin; Boronic Acids; Bortezomib; Heparin, Low-Molecular-Weight; Humans; Incidence; Lenalidomide; Multiple Myeloma; Oxides; Pyrazines; Thalidomide; Venous Thromboembolism | 2009 |
[Drugs and venous thromboembolism].
Topics: Angiogenesis Inhibitors; Aspirin; Estrogen Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Psychotropic Drugs; Thalidomide; Venous Thromboembolism | 2008 |
Interventions for erythema nodosum leprosum.
Topics: Aspirin; Clofazimine; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Prednisolone; Randomized Controlled Trials as Topic; Remission Induction; Thalidomide | 2009 |
Interventions for erythema nodosum leprosum. A Cochrane review.
Topics: Aspirin; Clofazimine; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Prednisolone; Randomized Controlled Trials as Topic; Thalidomide; Treatment Outcome | 2009 |
Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma.
Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Thalidomide; Thromboembolism; Warfarin | 2011 |
Thalidomide thromboprophylaxis in multiple myeloma: a review of current evidence.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Multiple Myeloma; Thalidomide; Venous Thromboembolism; Warfarin | 2012 |
[Treatment strategy for myeloproliferative neoplasms].
Topics: Adrenal Cortex Hormones; Aspirin; Calreticulin; Carbamates; Clinical Trials as Topic; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Immunosuppressive Agents; Janus Kinase 2; Molecular Targeted Therapy; Mutation; Nitriles; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Pyrazoles; Pyrimidines; Quinazolines; Receptors, Thrombopoietin; Thalidomide; Thrombocythemia, Essential | 2014 |
Refractory anemia with ring sideroblasts and RARS with thrombocytosis.
Topics: Anemia, Refractory; Anemia, Sideroblastic; Angiogenesis Inhibitors; Aspirin; Female; Humans; Iron Overload; Janus Kinase 2; Lenalidomide; Male; Mutation; Myelodysplastic Syndromes; Phosphoproteins; Platelet Aggregation Inhibitors; Receptors, Thrombopoietin; Ribonucleoprotein, U2 Small Nuclear; Risk Factors; RNA Splicing Factors; Thalidomide; Thrombocytosis | 2015 |
An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
Topics: Antineoplastic Agents; Aspirin; Digoxin; Diphosphonates; Drug Approval; Drug Discovery; Drug Repositioning; Humans; Itraconazole; Metformin; Nelfinavir; Thalidomide | 2016 |
Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review.
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Dexamethasone; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Risk; Thalidomide; Venous Thromboembolism | 2016 |
Update of thrombosis in multiple myeloma.
Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; Lenalidomide; Multiple Myeloma; Thalidomide; Thrombosis; Warfarin | 2016 |
7 trial(s) available for aspirin and thalidomide
Article | Year |
---|---|
[Therapeutic experience on the effect of thalidomidomide on lepra reaction].
Topics: Aspirin; Climate; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Israel; Leprosy; Male; Neural Conduction; Neurologic Manifestations; Placebos; Skin Manifestations; Steroids; Sulfones; Thalidomide; Ulnar Nerve; Uveitis, Anterior | 1975 |
WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients.
Topics: Acute Disease; Adolescent; Adult; Aspirin; Clinical Trials as Topic; Humans; Leprosy; Male; Middle Aged; Thalidomide; World Health Organization | 1971 |
The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Aspirin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Thalidomide; Venous Thrombosis; Vincristine | 2005 |
Tailored thromboprophylaxis for patients with multiple myeloma treated by IMIDs.
Topics: Aspirin; Chemoprevention; Humans; Lenalidomide; Multiple Myeloma; Thalidomide; Thrombosis | 2008 |
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Cardiovascular Diseases; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Italy; Male; Middle Aged; Multiple Myeloma; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thalidomide; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2011 |
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
Topics: Adult; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Enoxaparin; Female; Humans; Incidence; Israel; Italy; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Platelet Aggregation Inhibitors; Pulmonary Embolism; Risk Factors; Thalidomide; Venous Thromboembolism; Venous Thrombosis | 2012 |
Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Disease Progression; Disease-Free Survival; Female; Heparin; Humans; Kaplan-Meier Estimate; Lenalidomide; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Rituximab; Thalidomide; Thrombosis; Treatment Outcome | 2015 |
38 other study(ies) available for aspirin and thalidomide
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation.
Topics: Acetic Acid; Acetylation; Anemia, Sickle Cell; Dose-Response Relationship, Drug; Drug Discovery; gamma-Globins; Histones; Humans; K562 Cells; Molecular Structure; Nitric Oxide; Oxadiazoles; Structure-Activity Relationship | 2018 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Teratogenicity of therapeutic agents.
Topics: Abnormalities, Drug-Induced; Abnormalities, Radiation-Induced; Abortion, Induced; Anesthetics; Animals; Anticoagulants; Antineoplastic Agents; Aspirin; Congenital Abnormalities; Drug Evaluation; Drug Evaluation, Preclinical; Female; Hormones; Humans; Male; Methylmercury Compounds; Phenytoin; Pregnancy; Teratogens; Tetracycline; Thalidomide; Tranquilizing Agents; Trimethadione | 1979 |
A clinical look at the problem of drugs in pregnancy and their effect on the fetus.
Topics: Abnormalities, Drug-Induced; Anesthesia, Obstetrical; Aspirin; Drug-Related Side Effects and Adverse Reactions; Female; Fetus; Folic Acid Antagonists; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lidocaine; Maternal-Fetal Exchange; Meperidine; Mepivacaine; Nicotine; Physician-Patient Relations; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Scotland; Smoking; Thalidomide; United States | 1975 |
The management of reaction in leprosy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Aspirin; Benzenesulfonates; Chloroquine; Clofazimine; Cytotoxicity, Immunologic; Humans; Immunity, Cellular; Inflammation; Leprosy; Splints; Surgical Procedures, Operative; Thalidomide | 1989 |
Congenital malformations in nonhuman primates: spontaneous and experimentally induced.
Topics: Abnormalities, Drug-Induced; Aminopterin; Animals; Aspirin; Congenital Abnormalities; Female; Haplorhini; Hominidae; Meclizine; Norethindrone; Piperazines; Pregnancy; Pregnancy, Animal; Progesterone; Rubella virus; Testosterone; Thalidomide | 1967 |
Editorial: The pursuit of a chimera.
Topics: Acetaminophen; Animals; Aspirin; Barbiturates; Chloroform; Dogs; Drug-Related Side Effects and Adverse Reactions; Humans; Phenacetin; Thalidomide; Trichloroethylene; Tubocurarine | 1974 |
Problems associated with the screening of drugs for possible teratogenic activity.
Topics: 2,4,5-Trichlorophenoxyacetic Acid; Abnormalities, Drug-Induced; Animals; Aspirin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fertility; Heart Defects, Congenital; Heart Septal Defects; Kidney; Litter Size; Mice; Pharmaceutical Preparations; Pregnancy; Rabbits; Rats; Research Design; Respiration; Species Specificity; Spine; Teratogens; Thalidomide; Toxicology | 1974 |
Effects on macaque embryos of drugs reported or suspected to be teratogenic to humans.
Topics: Abnormalities, Drug-Induced; Aminopterin; Animals; Aspirin; Cesarean Section; Embryo, Mammalian; Female; Haplorhini; Macaca; Pregnancy; Quinine; Thalidomide | 1972 |
Sporadic malformations in laboratory animals and their influence on drug testing.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Laboratory; Aspirin; Bone and Bones; Congenital Abnormalities; Drug Evaluation, Preclinical; Face; Heart Defects, Congenital; Hemorrhage; Limb Deformities, Congenital; Lung; Mice; Osteogenesis; Pelvis; Rabbits; Rats; Ribs; Skull; Species Specificity; Spine; Sternum; Teratogens; Thalidomide; Urinary Tract | 1972 |
Drug toxicity in the animal fetus.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cats; Cricetinae; Dogs; Embryo, Mammalian; Female; Fetus; Haplorhini; Humans; Mice; Phenobarbital; Pregnancy; Rabbits; Rats; Thalidomide; Xenarthra | 1967 |
Teratogenicity studies.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Phenobarbital; Rabbits; Rats; Thalidomide | 1966 |
Effect of some therapeutic agents on the rabbit fetus.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Aspirin; Dimenhydrinate; Female; Fetus; Glutethimide; Methaqualone; Phenobarbital; Rabbits; Thalidomide; Tolbutamide; Tranquilizing Agents; Uterus | 1967 |
Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.
Topics: Animals; Aspirin; Dose-Response Relationship, Drug; Female; Pregnancy; Prostaglandins; Rabbits; Teratogens; Thalidomide | 1996 |
EFFECT OF ACETYLSALICYLIC ACID ON FOETAL RATS.
Topics: Abnormalities, Drug-Induced; Aspirin; Caseins; Fetus; Pharmacology; Pregnancy; Rats; Research; Reserpine; Stomach Ulcer; Sucrose; Thalidomide; Toxicology | 1964 |
EFFECT OF SOME THERAPEUTIC AGENTS ON THE DEVELOPING RAT FETUS.
Topics: Abnormalities, Drug-Induced; Animals; Antipyrine; Aspirin; Chloral Hydrate; Dimenhydrinate; Female; Fetal Development; Fetus; Humans; Pathology; Pharmacology; Pregnancy; Pregnancy, Animal; Rats; Research; Thalidomide; Tolbutamide; Toxicology | 1965 |
Arterial thrombosis in four patients treated with thalidomide.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Drug Therapy, Combination; Female; Humans; Intracranial Thrombosis; Lymphoma; Male; Middle Aged; Multiple Myeloma; Thalidomide; Thrombosis; Warfarin | 2005 |
Trials investigate first-line thalidomide in multiple myeloma.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Aspirin; Clinical Trials, Phase III as Topic; Dexamethasone; Drug Therapy, Combination; Humans; Multiple Myeloma; Thalidomide | 2005 |
Thalidomide therapy and deep venous thrombosis in multiple myeloma.
Topics: Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Immunosuppressive Agents; Multiple Myeloma; Thalidomide; Venous Thrombosis | 2005 |
Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspirin; Dexamethasone; Fibrinolytic Agents; Humans; Lenalidomide; Multiple Myeloma; Risk Factors; Thalidomide; Thromboembolism; Thrombosis; Treatment Outcome | 2006 |
Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Enoxaparin; Humans; Lenalidomide; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Recurrence; Risk; Thalidomide; Thromboembolism; Time Factors | 2006 |
Thalidomide causes platelet activation, which can be abrogated by aspirin.
Topics: Aspirin; Blood Platelets; Cell Aggregation; Humans; Monocytes; P-Selectin; Platelet Activation; Platelet Aggregation; Thalidomide; Venous Thrombosis | 2007 |
Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.
Topics: Adult; Aged; Antineoplastic Agents; Aspirin; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Thalidomide; Thrombosis | 2007 |
Aspirin as thromboprophylaxis in myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspirin; Chemoprevention; Humans; Lenalidomide; Multiple Myeloma; Thalidomide; Thrombosis | 2008 |
Comparative effects of drugs on P-glycoprotein expression and activity using rat and human trophoblast models.
Topics: Animals; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Dose-Response Relationship, Drug; Female; Humans; Methadone; Placenta; Pregnancy; Rats; Rats, Wistar; Thalidomide; Time Factors; Trophoblasts | 2010 |
New uses for older drugs: the tales of aspirin, thalidomide, and gabapentin.
Topics: Amines; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Aspirin; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Neoplasms; Peripheral Nervous System Diseases; Thalidomide | 2010 |
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
Topics: Activated Protein C Resistance; Aged; Anticoagulants; Aspirin; Boronic Acids; Bortezomib; Dexamethasone; Humans; Immunologic Factors; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin | 2011 |
Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
Topics: 5,8,11,14-Eicosatetraynoic Acid; 8-Hydroxy-2'-Deoxyguanosine; Animals; Aspirin; Brain; Deoxyguanosine; Embryo, Mammalian; Female; Hydrolysis; Limb Buds; Male; Molecular Structure; Oxidation-Reduction; Prostaglandin-Endoperoxide Synthases; Rabbits; Reactive Oxygen Species; Teratogens; Thalidomide; Tissue Culture Techniques | 2011 |
Thromboprophylaxis in multiple myeloma: is the evidence there?
Topics: Antineoplastic Agents; Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Immunomodulation; Multiple Myeloma; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Adjustment; Secondary Prevention; Thalidomide; Venous Thromboembolism; Warfarin | 2012 |
Recurrent aortic aneurysm due to Behcet's disease: a case report from China.
Topics: Adult; Anticoagulants; Aortic Aneurysm; Aortography; Aspirin; Behcet Syndrome; China; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Prednisone; Recurrence; Thalidomide; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Cancer Care Facilities; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Practice Patterns, Physicians'; Prognosis; Retrospective Studies; Specialization; Thalidomide; Thrombosis; Warfarin | 2013 |
A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of throm
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Female; Humans; Incidence; Japan; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Risk Factors; Thalidomide; Venous Thromboembolism; Warfarin | 2013 |
Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens.
Topics: Acenocoumarol; Age Factors; Antineoplastic Agents; Aspirin; Female; Genetic Predisposition to Disease; Heparin, Low-Molecular-Weight; Humans; Immunologic Factors; Lenalidomide; Male; Multiple Myeloma; NF-kappa B; Polymorphism, Single Nucleotide; Protein Subunits; Pulmonary Embolism; Thalidomide; Venous Thrombosis | 2013 |
Does the choice of thrombotic prophylactic drug depend on the known risk factors of patients with multiple myeloma in clinical practice?
Topics: Aged; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Lenalidomide; Male; Multiple Myeloma; Risk Factors; Thalidomide; Thrombosis; Vitamin K | 2016 |
Treatment of Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data from a Single Institution.
Topics: Adult; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Bortezomib; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Maintenance Chemotherapy; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Survival Rate; Thalidomide | 2020 |